Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Srinivas Akkaraju reported a 9.10% stake in Mineralys Therapeutics, Inc. (Schedule 13D/A)

Event Mar 13, 2025 · Filed Mar 17, 2025

Srinivas Akkaraju reported a 9.10% stake in Mineralys Therapeutics, Inc., 5,736,305 shares, with active intent on Mar 13, 2025. Filed Mar 17, 2025 (Schedule 13D/A).

Stake
9.10%
Shares
5,736,305
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.9.00%5,674,916
Samsara BioCapital GP, LLC9.00%5,674,916
Srinivas Akkaraju9.10%5,736,305

Source

View original at SEC

Related